Substituted aryl 1.4-pyrazine derivatives background of the invention

Details for Australian Patent Application No. 2006238976 (hide)

Owner Pfizer Products Inc.

Inventors Hoffman, Robert Louis; Verhoest, Patrick Robert

Agent Shelston IP

Pub. Number AU-A-2006238976

PCT Pub. Number WO2006/114666

Priority 60/662,917 17.03.05 US

Filing date 6 March 2006

Wipo publication date 2 November 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/497 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/114666 Priority application(s): WO2006/114666

4 March 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Substituted aryl 1,4-pyrazine derivatives

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006238984-Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes

2006238975-Method of migrating RFID transponders in situ